Skip to content
RDL Network logo
Supplementary Data from A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma — Giselle L. Saulnier Sholler (2023) | RDL Network